Navigation Links
CoreSpine Technologies(TM) Receives Clearance to Market Surgical Disc Preparation Device
Date:5/4/2009

Company Achieves Major Milestone with Limited Start-up Funding

MINNEAPOLIS, May 4 /PRNewswire/ -- CoreSpine Technologies, a Minneapolis-based spinal device developer, announced today it has received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) for its XTEND-ST(TM) Nucleus Removal System.

"The clearance of the XTEND-ST device is truly a significant achievement for CoreSpine," said Christine Horton, Chief Executive Officer of CoreSpine Technologies. "The XTEND-ST is a safe and effective device for removing lumbar disc material and satisfies a large unmet need within the spine industry. Of equal significance is that CoreSpine was able to develop the product with minimal funding over the past three years. I credit the many dedicated and talented medical device professionals that work with CoreSpine and the company's ability to operate lean yet with a defined purpose."

"The need for CoreSpine's technology increases as additional spinal implants and new approaches are introduced to spine surgeons," said John Sherman, M.D., spine surgeon with Twin Cities Orthopedics in Minneapolis, Minnesota. Dr. Sherman continued, "I continue to be impressed with the company's history of developing new technology with limited funds."

About CoreSpine Technologies, LLC

CoreSpine Technologies, LLC is a privately held spinal device manufacturer headquartered in Minneapolis, Minnesota. The company's focus is on expanding its platform technology to produce advanced surgical devices for the complete or selective removal of material from the lumbar disc space. The first products will initially set the standard for preparing the spinal disc for minimally invasive fusion with applications in a variety of emerging spinal therapies. For additional information, please visit the company's website at www.corespinetech.com
'/>"/>

SOURCE CoreSpine Technologies, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Baxa Corporation Acquires Florida-Based ForHealth Technologies(TM)
2. Insurance Defense Law Firm Receives Recognition from Martindale-Hubbell
3. BMP Sunstone Receives Nasdaq Compliance Notice
4. BMP Sunstone Compliance Receives Nasdaq Notice
5. Stratfords Institutional Investment Consulting Service Receives HFMA Peer Review Designation
6. Excelsior Medical Corporation Receives FDA Approval to Market SwabCap(TM) Luer Access Valve Disinfection Cap
7. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
8. IMRIS receives CE Mark approval for interventional imaging system
9. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
10. Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award
11. SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... by a researcher from the Cancer Science Institute of ... has identified the cancer specific stem cell which causes ... developing new drugs for the treatment of this disease ... led by Dr Chan Shing Leng, Research Assistant Professor ... a cancer-specific variant of a cell surface protein, CD44v8-10, ...
(Date:4/23/2014)... may prevent the depletion of self-control, according to research ... the Association for Psychological Science. , Self-control can be ... focus attention on a boring textbook are hard things ... this difficulty: Exerting self-control for a long period seems ... subsequent tasks. , "It is as if self-control is ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
(Date:4/22/2014)... 2014 Researchers at UT Southwestern Medical Center are ... depression . , A team of physician-scientists at ... ghrelin (a hormone with natural anti-depressant properties) works inside ... new treatment for depression in the form of a ... study, published online in April,s issue of Molecular ...
(Date:4/22/2014)... 22, 2014) The International Communication Association will ... Seattle, Washington. The theme of the 2014 conference ... a networked and digital society. , Featuring over ... over 2,200 Communication scholars representing over 40 countries, ... communication conference in the world. This year,s conference ...
Breaking Medicine News(10 mins):Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2
... 4 (HealthDay News) -- The quality of family mealtimes ... research suggests. In the study, U.S. researchers observed ... children aged 5 to 12 with persistent asthma. ... or in a particular season, children with persistent asthma ...
... , FRIDAY, Feb. 4 (HealthDay News) -- The death of ... typically seen directed toward live infants, but it,s unclear whether ... may help improve understanding of how chimpanzees, one of humans, ... study authors noted. In the study, the researchers ...
... News) -- Safety labels that outline concerns about medications, ... within drug categories, a new study suggests. These ... a single class of drugs, according to a team ... team also advised that supplemental warnings (for example, following ...
... is blamed on a failure of innovative drive in the ... of venture capital to invest in early stage research, or ... , A research centre funded by the Economic and Social ... industry regulatory system must be an important part of the ...
... Gordon HealthDay Reporter , THURSDAY, Feb. 3 ... reduce symptoms of attention-deficit hyperactivity disorder (ADHD) in young ... the ages of 4 and 8 were placed on ... ADHD symptoms diminished in 78 percent of them. And, ...
... THURSDAY, Feb. 3 (HealthDay News) -- Although blacks make up only ... of all diagnosed cases of HIV, federal health officials reported Thursday. ... times that of whites, and the rate for black women is ... data from 37 states by the U.S. Centers for Disease Control ...
Cached Medicine News:Health News:Quality of Family Mealtimes May Affect Kids' Asthma 2Health News:'Black Box' Drug Warning Labels Applied Inconsistently: Study 2Health News:Tipping points -- the future of the pharmaceutical industry 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News: Burden of HIV Highest for Blacks, CDC Reports 2Health News: Burden of HIV Highest for Blacks, CDC Reports 3
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Congressional Leaders to Introduce Legislation , WASHINGTON , ... Congressional Network (ACPCN) will join congressional leaders tomorrow to ... Savings Act." The bill by U.S. Rep. G.K. ... management (PBM) companies for medications. , "Congress is prepared ...
... AMD LASERS, the world leader in comprehensive and affordable ... Waclawik as Chief Operating Officer. In this newly created ... operations, procurement, production, quality assurance, and general financial oversight ... effort on the next-generation of product development in order ...
Cached Medicine Technology:Pharmacists Work with Congress to Address PBM Abuses 2AMD LASERS Announces the Addition of Bart Waclawik, New Chief Operating Officer 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: